about
Feed forward artificial neural network: tool for early detection of ovarian cancer.Alginate coated chitosan microparticles mediated oral delivery of diphtheria toxoid. Part A. Systematic optimization, development and characterization.Receptor-based targeting of therapeutics.A review of ligand tethered surface engineered carbon nanotubes.siRNA nanotherapeutics: a Trojan horse approach against HIV.Validating the anticancer potential of carbon nanotube-based therapeutics through cell line testing.Dendrimer technologies for brain tumor.Dendrimer-mediated approaches for the treatment of brain tumor.Bilosomes in the context of oral immunization: development, challenges and opportunities.The development, characterization and in vivo anti-ovarian cancer activity of poly(propylene imine) (PPI)-antibody conjugates containing encapsulated paclitaxel.Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.Recent advances in galactose-engineered nanocarriers for the site-specific delivery of siRNA and anticancer drugs.Biodegradable nanoparticles as theranostics of ovarian cancer: an overview.Carbon dots: emerging theranostic nanoarchitectures.Stomach specific polymeric low density microballoons as a vector for extended delivery of rabeprazole and amoxicillin for treatment of peptic ulcer.Quality by design (QbD) approaches in current pharmaceutical set-upCurrent Strategies and Drug Targets in the Management of Type 2 Diabetes MellitusSolid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery SystemsDelonix regia: historic perspectives and modern phytochemical and pharmacological researchesBiomedical Applications and Toxicological Aspects of Functionalized Carbon NanotubesNovel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overviewBilayer Tablet Based Chronotherapeutics in the Management of Nocturnal Asthma: An OverviewDendrimer Based Nanoarchitectures in Diabetes Management: An OverviewDynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental ColitisAlbumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1αNucleic Acid Aptamers as a Potential Nucleus Targeted Drug Delivery System
P50
Q35185305-50B7E2C2-ED81-43BE-9882-82512314DE84Q35759688-5958EFD2-F746-415B-B7BC-5CF6DD48A384Q38084739-EB333B35-D3BB-4CD8-8560-368F3E75F824Q38161179-2CEAB0DB-AD28-4CE7-848F-D76F734D5BD6Q38256626-8332FE7F-21E2-4A29-B1F9-357031AD2101Q38495939-1B4F8E4D-FAF3-4CBA-8CE5-C7047C6EC5E3Q38739680-63EBC053-ECDA-42F6-942E-E8EE759FD013Q38755622-0BA88893-BE75-408F-A8D3-B5362FCD2FE0Q38796391-80A4BF09-D68C-40F7-9878-2B102F716B88Q38952675-0B92B3D5-EE31-4E90-B9DC-5377D1D23557Q44108770-04F0D9D1-6B13-4C78-9155-B03880585B7EQ47356758-C6F0BE7C-1BB1-4082-A7BB-4412F7D849B1Q47705378-7DC16BDF-9909-40EE-B5AC-E32BDC1A9A25Q49794224-F1625EBE-9C5C-4A60-B767-03243ADC0FE5Q50534981-F8C06770-3BCD-4AE4-A486-6E7B73344AC8Q57172143-A5AFB2BD-B6BA-40F6-8705-7C982D4BC090Q57174379-091FA26A-A1C0-43FD-9734-FF743D65E06CQ57812853-AFA96435-EBF6-4E25-BD81-15A45B59B48EQ62492188-E97FF414-B9A0-4EEA-B4B8-C86492553988Q89419123-A29CEF3E-20BD-4435-A98E-289E32787DD4Q91006617-26E1F9E4-6A91-48C6-B1A7-5173237DA2E2Q92080841-0FC3AB95-56A9-4B44-9DBA-F7BEE3782FF4Q92102349-ACB04477-9CA0-43F8-A376-6C607685B5FBQ92391500-1F12B58E-CB6D-4095-A813-DDA66D78E176Q92446404-1CB019E7-4D20-4DE5-820E-08840F08D3B9Q92449996-1856FEA4-BB53-48EC-8061-95D76CB3E4E0
P50
description
investigador
@es
researcher
@en
name
Vijay Mishra
@en
type
label
Vijay Mishra
@en
prefLabel
Vijay Mishra
@en
P31
P496
0000-0001-6542-2464